Layoffs
Filter News
Found 129 articles
-
The Novartis Institutes for BioMedical Research (NIBR) is ending its early-stage anti-infectives research programs located in Emeryville, California. As a result, the company expects to lay off about 140 employees.
-
Changes continue coming to Vivek Ramaswamy’s Roivant Sciences following a June shakeup that saw a 10 percent cut in employment and the restructuring of its business operations.
-
Beleaguered Regulus Therapeutics Slashes 60 Percent of Workforce in New Corporate Restructuring
7/10/2018
Shares of Regulus Therapeutics saw something of a slight rally on Monday following a post-Independence Day corporate restructuring announcement that included the termination of 60 percent of its workforce, which caused a massive stock plummet. -
Roivant Sciences, Vivek Ramaswamy’s umbrella company for his family of “Vants,” announced major restructuring that includes a cut of 10 percent of staff and reshuffling of leadership.
-
Purdue Pharma, best known for selling painkiller OxyContin, announced it laid off approximately 350 staffers.
-
IBM recently reported a round of layoffs at its Watson Health unit, which uses artificial intelligence (AI) to work in healthcare.
-
Flex Pharma announced in a Corporate Update that it is closing an ongoing Phase II clinical trial of FLX-787 in ALS and CMT while shifting its strategy to focus on other approaches.
-
Danish company Novo Nordisk is reportedly considering cost-cutting plans that would cut up to 3,000 jobs.
-
In a recent interview, Ron Cohen, chief executive officer of Acorda Therapeutics, indicated that if the company lost its appeals over patent lawsuits for its Ampyra for multiple sclerosis, there would not be layoffs in its sales force.
-
MNA: UMass Memorial Health Alliance in Leominster Plans to Close Pediatric Unit Depriving Children and Families of Access to Care Close to Home
5/29/2018
UMass Memorial Health Care (UMMHC) has announced plans to close yet another service, this time it's the 12-bed pediatric unit on the Leominster Hospital campus of UMass Memorial Health Alliance - Clinton Hospital.
-
One month after Prothena Corporation shuttered its NEOD001 program for AL amyloidosis following a Phase IIb failure, the company initiated a reorganization that includes a workforce reduction of 57 percent.
-
The first Novartis executive has fallen in the wake of the $1.2 million payment to President Donald Trump’s attorney for consulting work.
-
aTyr Pharma Slashes 30% of Employees as it Initiates Corporate Restructuring Following ORCA Failure
5/14/2018
Shares of San Diego-based aTyr Pharma are down nearly 20 percent this morning after the company announced a corporate restructuring plan that includes a 30 percent reduction of staff following failures of its preclinical ORCA program. -
Amneal Announces Actions to Streamline Operations and Capture Cost Synergies
5/11/2018
Company will close its Hayward, California-based facilities and operations.
-
On April 16, Celldex Therapeutics reported that its Phase IIb trial of glembatumumab vedotin (glemba) failed in a trial of metastatic triple-negative breast cancer. Now the company has filed with the U.S. Securities and Exchange Commission (SEC) that it is cutting about 20 percent of staff.
-
Shares of Edge Therapeutics were in free fall Wednesday afternoon following the company’s decision to discontinue development of a late stage treatment for adults with aneurysmal subarachnoid hemorrhage (aSAH).
-
Achillion is handing out pink slips to 20 percent of its employees and initiating an operational restructuring plan.
-
The news was revealed in a filing with the SEC.
-
ImmunoGen gave a pipeline progress report and 2017 operating results last week.